Magnesium SO4 is one of 257 small molecule programs targeting Sedation. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1050 competitors in Asthma
Magnesium SO4
Veramyst
Singulair
Aciphex
Decadron
Solu-Medrol
Blood Withdrawn
Aclidinium Bromide
Blood Collection
Spiriva
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details